Terri shares her stage 3A KRAS+ lung cancer story, including experiencing three separate recurrences. She persevered through multiple...

American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the...

763: That is how many consecutive days I had been running at least one mile—also known as a running streak. Surgery ended that. On what...

We’ve all heard the cliche....”Listen to your body because it’s trying to tell you something.” I can’t begin to tell you how true that...

We spoke with Mary C., a 69 year-old retired healthcare worker from Nova Scotia, who also worked as an oncology nurse for several years. ...

On March 22, 2021 we spoke with Val R. Val is currently 28 years old. In May of 2019, at age 26, she was diagnosed with invasive...

Treatment with the KRAS G12C inhibitor adagrasib showed clinical activity in patients with advanced non–small cell lung cancer (NSCLC)...

Clinical activity with a second drug inhibiting KRASG12C confirms its role as a therapeutic target in patients with advanced...

Eli Lilly has rejoined the KRAS race months after toxicity forced it to dump its first candidate. The Big Pharma is set to enter phase 1...